Concert Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-13,910
Closed -$1.02M 308
2017
Q1
$1.02M Buy
13,910
+1,514
+12% +$121K 0.23% 124
2016
Q4
$911K Sell
12,396
-9,084
-42% -$677K 0.2% 142
2016
Q3
$1.72M Buy
21,480
+337
+2% +$27K 0.21% 118
2016
Q2
$1.68M Buy
21,143
+1,643
+8% +$124K 0.23% 113
2016
Q1
$1.4M Buy
19,500
+1,931
+11% +$146K 0.19% 135
2015
Q4
$1.48M Buy
17,569
+360
+2% +$29.9K 0.2% 127
2015
Q3
$1.44M Buy
17,209
+392
+2% +$33.1K 0.19% 130
2015
Q2
$1.4M Buy
16,817
+585
+4% +$44.6K 0.18% 140
2015
Q1
$676K Buy
16,232
+3,136
+24% +$223K 0.19% 152
2014
Q4
$905K Buy
13,096
+6,621
+102% +$447K 0.14% 194
2014
Q3
$412K Sell
6,475
-200
-3% -$12.7K 0.06% 311
2014
Q2
$398K Sell
6,675
-113
-2% -$6.74K 0.05% 343
2014
Q1
$398K Sell
6,788
-373
-5% -$20.8K 0.05% 332
2013
Q4
$364K Sell
7,161
-454
-6% -$22.7K 0.05% 332
2013
Q3
$384K Sell
7,615
-39
-0.5% -$2.04K 0.05% 310
2013
Q2
$379K Buy
+7,654
New +$416K 0.06% 284

Other funds holding LLY

Concert Wealth Management's LLY Position: Q2 2017 in Review

Concert Wealth Management sold out of Eli Lilly (LLY) in Q2 2017, closing a stake of 13,910 shares — an estimated $1.02M sold.

Concert Wealth Management first reported a position in LLY in Q2 2013 and held it in 16 quarters. The position peaked at $1.72M in Q3 2016. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Concert Wealth Management reported no remaining Eli Lilly position as of Q2 2017 after selling out during the quarter.
  • Concert Wealth Management sold 13,910 Eli Lilly shares in Q2 2017, an estimated $1.02M.
  • Concert Wealth Management first reported a position in Eli Lilly in Q2 2013 and held it in 16 quarters.
  • Concert Wealth Management's Eli Lilly position peaked at $1.72M in Q3 2016.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.